PMID- 22769861
OWN - NLM
STAT- MEDLINE
DCOM- 20121109
LR  - 20220321
IS  - 1875-452X (Electronic)
VI  - 50
IP  - 2
DP  - 2012 Jun
TI  - Migraine diagnosis: screening items, instruments, and scales.
PG  - 69-73
LID - 10.1016/j.aat.2012.05.002 [doi]
AB  - Migraine is a common and disabling disorder with a 1-year prevalence of 4.5-6% in 
      men and 14.5-18% in women. The diagnosis of migraine is usually made according to 
      the second edition of the International Classification of Headache Disorders 
      (ICHD-2) criteria; however, not all physicians are familiar with the diagnostic 
      criteria. Underdiagnosis remains a major issue in general practice, resulting in 
      inadequate treatment. Several instruments are designed to improve the diagnosis 
      of migraine, to identify the comorbid psychological disturbances, to measure the 
      burden and disability, and to access any reduction in quality of life (QoL) that 
      occurs due to migraine attacks with good reliability and validity. Furthermore, 
      the disability and QoL measured by certain instruments serve as surrogate targets 
      when treating migraines. In this review, we examine the instruments that are in 
      common use in daily practice and current research on migraines, focusing on the 
      purpose of each instrument, clinical applications, pitfalls in interpretation, 
      and, if any, minimally clinically important difference(s) (MCID). In general, a 
      structured intake form and a headache diary are recommended in approaching 
      patients with headache. In addition, ID-Migraine, a three-item screening test, 
      has been validated in primary care settings as a way to improve the rapid 
      diagnosis of migraine. The Visual Aura Rating Scale (VARS) is helpful for the 
      diagnosis of migraine with aura. In addition, migraine is commonly associated 
      with psychiatric comorbidities, which can be assessed by the Beck Depression 
      Inventory (BDI), 9-item Patient Health Questionnaire (PHQ-9), and Hospital 
      Anxiety and Depression Scale (HADS). To evaluate the impact of migraines, 
      disability can be assessed using the Migraine Disability Assessment Questionnaire 
      (MIDAS). Reduction in QoL can be evaluated using the Migraine-Specific Quality of 
      Life Survey (MSQ 2.1), European Quality of Life-Five Dimensions (EQ-5D), or 
      Short-Form 36 (SF-36). Despite all these instruments, proper selection and 
      interpretation of each instrument remain crucial.
CI  - Copyright (c) 2012. Published by Elsevier B.V.
FAU - Peng, Kuan-Po
AU  - Peng KP
AD  - Department of Neurology, Neurological Institute, Taipei Veterans General 
      Hospital, Taiwan.
FAU - Wang, Shuu-Jiun
AU  - Wang SJ
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20120619
PL  - China (Republic : 1949- )
TA  - Acta Anaesthesiol Taiwan
JT  - Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of 
      Anesthesiologists
JID - 101214918
SB  - IM
MH  - Comorbidity
MH  - Disability Evaluation
MH  - General Practitioners
MH  - Humans
MH  - Mental Disorders/diagnosis
MH  - Migraine Disorders/*diagnosis/psychology
MH  - Quality of Life
EDAT- 2012/07/10 06:00
MHDA- 2012/11/10 06:00
CRDT- 2012/07/10 06:00
PHST- 2012/03/23 00:00 [received]
PHST- 2012/04/17 00:00 [revised]
PHST- 2012/04/20 00:00 [accepted]
PHST- 2012/07/10 06:00 [entrez]
PHST- 2012/07/10 06:00 [pubmed]
PHST- 2012/11/10 06:00 [medline]
AID - S1875-4597(12)00037-9 [pii]
AID - 10.1016/j.aat.2012.05.002 [doi]
PST - ppublish
SO  - Acta Anaesthesiol Taiwan. 2012 Jun;50(2):69-73. doi: 10.1016/j.aat.2012.05.002. 
      Epub 2012 Jun 19.